In patients not receiving an auto-SCT that presented MM progression, cumulative incidence of mortality was higher in patients with the CD200 rs1131199 GG genotype than in the CC or CG genotypes, but this difference did not reach statistical significance (p= 0.06) (Figure 4A). The gene discussed is CD200; the disease is Miyoshi myopathy.